Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
April 29, 1997
Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity
Y Reiter, A Di Carlo, L Fugger, et al.
Protein Engineering
|
December 1, 1995
Disulfide stabilization of antibody Fv: computer predictions and experimental evaluation
Y Reiter, U Brinkmann, S H Jung, et al.
Cancer Research
|
May 15, 1994
Antitumor activity and pharmacokinetics in mice of a recombinant immunotoxin containing a disulfide-stabilized Fv fragment
Y Reiter, L H Pai, U Brinkmann, et al.
European Journal of Immunology
|
November 28, 2000
Recombinant human single-chain MHC-peptide complexes made from E. coli By in vitro refolding: functional single-chain MHC-peptide complexes and tetramers with tumor associated antigens
G Denkberg, C J Cohen, D Segal, et al.
International Journal of Cancer
|
August 24, 2001
K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement
K Jurianz, S Ziegler, N Donin, et al.
Protein Engineering
|
May 1, 1994
Engineering interchain disulfide bonds into conserved framework regions of Fv fragments: improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv
Y Reiter, U Brinkmann, K O Webber, et al.
Biochemistry
|
May 10, 1994
Stabilization of the Fv fragments in recombinant immunotoxins by disulfide bonds engineered into conserved framework regions
Y Reiter, U Brinkmann, R J Kreitman, et al.
Cytotherapy
|
January 17, 2009
Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy
M J Besser, E Schallmach, K Oved, et al.
Immunobiology
|
September 1, 1991
Resistance to NK cell-mediated cytotoxicity (in K-562 cells) does not correlate with class I MHC antigen levels
Z Reiter, Y Reiter, Z Fishelson, et al.
Immunity
|
March 1, 1995
Construction of a functional disulfide-stabilized TCR Fv indicates that antibody and TCR Fv frameworks are very similar in structure
Y Reiter, I Kurucz, U Brinkmann, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Proceedings of the National Academy of Sciences of the United States of America
|
April 29, 1997
Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity
Y Reiter, A Di Carlo, L Fugger, et al.
Protein Engineering
|
December 1, 1995
Disulfide stabilization of antibody Fv: computer predictions and experimental evaluation
Y Reiter, U Brinkmann, S H Jung, et al.
Cancer Research
|
May 15, 1994
Antitumor activity and pharmacokinetics in mice of a recombinant immunotoxin containing a disulfide-stabilized Fv fragment
Y Reiter, L H Pai, U Brinkmann, et al.
European Journal of Immunology
|
November 28, 2000
Recombinant human single-chain MHC-peptide complexes made from E. coli By in vitro refolding: functional single-chain MHC-peptide complexes and tetramers with tumor associated antigens
G Denkberg, C J Cohen, D Segal, et al.
International Journal of Cancer
|
August 24, 2001
K562 erythroleukemic cells are equipped with multiple mechanisms of resistance to lysis by complement
K Jurianz, S Ziegler, N Donin, et al.
Protein Engineering
|
May 1, 1994
Engineering interchain disulfide bonds into conserved framework regions of Fv fragments: improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv
Y Reiter, U Brinkmann, K O Webber, et al.
Biochemistry
|
May 10, 1994
Stabilization of the Fv fragments in recombinant immunotoxins by disulfide bonds engineered into conserved framework regions
Y Reiter, U Brinkmann, R J Kreitman, et al.
Cytotherapy
|
January 17, 2009
Modifying interleukin-2 concentrations during culture improves function of T cells for adoptive immunotherapy
M J Besser, E Schallmach, K Oved, et al.
Immunobiology
|
September 1, 1991
Resistance to NK cell-mediated cytotoxicity (in K-562 cells) does not correlate with class I MHC antigen levels
Z Reiter, Y Reiter, Z Fishelson, et al.
Immunity
|
March 1, 1995
Construction of a functional disulfide-stabilized TCR Fv indicates that antibody and TCR Fv frameworks are very similar in structure
Y Reiter, I Kurucz, U Brinkmann, et al.
Page
of 4